SELENOP and metabolic syndrome: Increased plasma selenoprotein P levels in T2DM patients (Misu et al., 2010; Yang et al., 2011)Increased concentrations of selenoprotein P decrease the risk of metabolic syndrome (Gharipour et al., 2017)